Skip Navigation LinksHome > June 2012 - Volume 7 - Issue 6 > Welcome to the 3rd European Lung Cancer Conference
Journal of Thoracic Oncology:
doi: 10.1097/JTO.0b013e318253d441
Introduction

Welcome to the 3rd European Lung Cancer Conference

Passlick, Bernward; Stahel, Rolf A.

Free Access
Collapse Box

Author Information

Scientific Committee Co-Chairs

On behalf of The European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC), it gives us great pleasure to welcome you to the 3rd European Lung Cancer Conference.

After two successful Conferences, for the goal of the ELCC is still to provide a comprehensive overview of the most significant advances in lung cancer research and treatment and to deliver an outstanding program with the right balance of clinical relevance, which covers the entire spectrum of practice issues in lung cancer. Treatment must be approached by multiple specialists who aim to provide a personalized treatment strategy for every patient therefore there is a strong multidisciplinary influence in the program.

We trust that participants will benefit from the high value, scope and depth of the information on: tumor biology, pathology, prevention, early detection, epidemiology, tobacco control, imaging, staging, management-related issues and translational and clinical research, presented with the emphasis on interdisciplinary challenges and supported by clinical interpretations needed for application of recent studies.

A sincere thank you to the 2012 scientific committee, invited speakers, organizers and sponsors for their commitment to this Conference. We hope that you enjoy the meeting enough to join us again in 2014.

Bernward Passlick and Rolf A. Stahel

Scientific Committee Co-Chairs

© 2012International Association for the Study of Lung Cancer

Login

Article Tools

Share

Other Ways to Connect

Twitter
twitter.com/JTOonline

 



Visit JTO.org on your smartphone. Scan this code (QR reader app required) with your phone and be taken directly to the site.

 For additional oncology content, visit LWW Oncology Journals on Facebook.